Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 9:28 PM
Ignite Modification Date:
2025-12-25 @ 7:14 PM
NCT ID:
NCT02203032
Group ID:
EG000
Title:
Ustekinumab (Open Label Run-in)
Description:
All participants received ustekinumab 45 milligram (mg) (participants weighing less than or equal to \[\<=\]100 kilogram \[kg\]) or 90 mg (participants weighing \>100 kg) at Weeks 0 and 4. At Week 16, participants with IGA \>=2 were randomized to either switch to guselkumab 100 mg at Weeks 16 and 20 and then every 8 weeks thereafter or continue on ustekinumab every 12 weeks (q12w); participants with an IGA=0 or 1 were to continue to receive open-label ustekinumab q12w.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
11
Serious Number At Risk:
871
Other Number Affected:
80
Other Number At Risk:
871
Study:
NCT02203032
Results Section:
NCT02203032
Adverse Events Module:
NCT02203032